EP3302485
CERDULATINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES
:
EP einkaleyfi: Þýðing ekki lögð inn:
27.5.2016:
12.7.2023:
16804177.0
:
26.5.2036
:
CERDULATINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES
27.5.2016
12.7.2023
:
Alexion Pharmaceuticals, Inc.:
121 Seaport Boulevard, Boston, MA 02210, US
:
PANDEY, Anjali:
South San Francisco, California 94080, US
:
COFFEY, Gregory:
South San Francisco, California 94080, US
:
LEEDS, Janet:
South San Francisco, California 94080, US
:
201562168530 P:
29.5.2015:
US
:
201562263582 P:
4.12.2015:
US
:
US2016034861:
27.5.2016
:
A61K 31/506, A61P 35/02